Filing Details
- Accession Number:
- 0000899243-22-011432
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-03-17 17:14:49
- Reporting Period:
- 2022-01-06
- Accepted Time:
- 2022-03-17 17:14:49
- Original Submission Date:
- 2022-01-25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658551 | Amylyx Pharmaceuticals Inc. | AMLX | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543112 | Ltd Investments Venture Morningside | C/O Thc Management Services S.a.m. 3-5 Avenue Des Citronniers Monaco O9 MC 98000 | No | No | Yes | No | |
| 1914583 | Mvil, Llc | C/O 22Nd Floor, Hang Lung Centre 2-20 Paterson St. Causeway Bay, Hong Kong K3 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-11 | 10,415,650 | $0.00 | 10,415,650 | No | 4 | C | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2022-01-11 | 263,158 | $19.00 | 10,678,808 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnotes |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2022-01-11 | 1,409,035 | $0.00 | 1,409,035 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2022-01-11 | 6,410,964 | $0.00 | 6,410,964 | $0.00 |
| Common Stock | Series C-1 Preferred Stock | Disposition | 2022-01-11 | 974,107 | $0.00 | 974,107 | $0.00 |
| Common Stock | Series C-2 Preferred Stock | Disposition | 2022-01-11 | 1,621,544 | $0.00 | 1,621,544 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the "Preferred Stock") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date.
- Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC.
- The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC.
Billionaire Hedge Funds
